Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure.

[1]  B. Holman,et al.  A simplified technique for measuring right ventricular ejection fraction using the equilibrium radionuclide angiocardiogram and the slant-hole collimator. , 1981, Radiology.

[2]  J. Cohn,et al.  Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure. , 1980, The American journal of cardiology.

[3]  E. Braunwald,et al.  Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.

[4]  L. Johnson,et al.  Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. , 1980, The American journal of medicine.

[5]  L. Johnson,et al.  Right ventricular ejection fraction during exercise in patients with coronary artery disease. , 1979, Circulation.

[6]  C. Conti,et al.  Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure. , 1979, British heart journal.

[7]  D. Berman,et al.  A New Technique for Assessing Right Ventricular Ejection Fraction Using Rapid Multiple‐gated Equilibrium Cardiac Blood Pool Scintigraphy: Description, Validation and Findings in Chronic Coronary Artery Disease , 1979, Circulation.

[8]  J. Ruskin,et al.  Primary pulmonary hypertension treated with oral phentolamine. , 1979, Annals of internal medicine.

[9]  W. Pettinger,et al.  Drug therapy. Prazosin. , 1979, The New England journal of medicine.

[10]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[11]  J A Parker,et al.  Ejection fraction image: a noninvasive index of regional left ventricular wall motion. , 1978, The American journal of cardiology.

[12]  R. Matthay,et al.  Assessment of cardiac performance with quantitative radionuclide angiocardiography: right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease. , 1978, The American journal of cardiology.

[13]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[14]  R. Miller,et al.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.

[15]  B. Massie,et al.  Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.

[16]  J. Cohn,et al.  Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.

[17]  P. Kadowitz,et al.  Effect of Sympathetic Nerve Stimulation on Pulmonary Vascular Resistance in the Dog , 1973, Circulation research.

[18]  D. Ramsay,et al.  The site of action of nerves in the pulmonary vascular bed in the dog , 1970, The Journal of physiology.

[19]  Y. Yoshida.  Studies on the pathologic physiology of pulmonary hypertension in mitral valvular disease. 1. The role of sympathetic nervous system on the increment of pulmonary vascular resistance. , 1969, Japanese circulation journal.

[20]  Y. Yoshida.  Studies on the pathologic physiology of pulmonary hypertension in mitral valvular disease-1,2- , 1969 .

[21]  吉田 浩.  Studies on the pathologic physiology of pulmonary hypertension in mitral valvular disease , 1969 .

[22]  G. Bousvaros.  EFFECTS OF NOREPINEPHRINE ON HUMAN PULMONARY CIRCULATION , 1962, British heart journal.

[23]  D. J. Patel,et al.  Some Evidence for Active Constriction in the Human Pulmonary Vascular Bed , 1958, Circulation.